Evaluating the impact of parasternal blockade on serum lactate levels in cardiac surgery
Serum Lactate in the Application of Parasternal Blockade in Trans and Post Anesthetic Stages in Cardiac Surgery
This study is testing if a specific pain relief method used during heart surgery can lower lactate levels in the blood and help patients recover better after the operation.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 86 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Instituto Mexicano del Seguro Social Government |
| Locations | 1 site (Guadalajara, Jalisco) |
| Trial ID | NCT06516432 on ClinicalTrials.gov |
What this trial studies
This study investigates the relationship between parasternal blockade and serum lactate levels in patients undergoing elective cardiac surgery. It aims to determine if the use of parasternal blockade can reduce postoperative inflammatory responses and improve patient outcomes by analyzing lactate levels during and after anesthesia. The study compares patients who received the parasternal block with those who did not, focusing on changes in serum lactate levels within the first 24 hours post-surgery. Conducted at Specialty Hospital CMNO, this analytical cross-sectional study includes adult patients undergoing median sternotomy and cardiopulmonary bypass.
Who should consider this trial
Good fit: Ideal candidates are adult patients over 18 years old undergoing elective cardiac surgery with ASA II-III classification.
Not a fit: Patients with pre-existing conditions that could independently affect serum lactate levels may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved postoperative outcomes and reduced morbidity and mortality in cardiac surgery patients.
How similar studies have performed: While the specific approach of this study may be novel, similar studies have shown that interventions like parasternal blockade can positively influence postoperative outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients older than 18 years * Either sex * ASA II-III * Patients who underwent cardiac surgery with median sternotomy and use of cardiopulmonary bypass. Exclusion Criteria: * Patients with pre-existing conditions that could independently affect serum lactate levels.
Where this trial is running
Guadalajara, Jalisco
- Centro Médico Nacional de Occidente — Guadalajara, Jalisco, Mexico (Recruiting)
Study contacts
- Principal investigator: Alejandro Gonzalez, 3 — Imss
- Study coordinator: Alejandro Gonzalez, 3
- Email: avygail5@gmail.com
- Phone: 3331294165
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.